Russell Investments Group
CASC

Russell Investments Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Russell Investments Group’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,200
Closed -$43K – 3095
2017
Q4 		$43K Buy
+11,200
New +$43K ﹤0.01% 2884